Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Cardiac Disease
Interventions
DEVICE

CIED envelope

Evaluation of the difference in cohorts for soft tissue healing surrounding the CIED implant and clinical outcomes and complications.

Trial Locations (11)

10032

Columbia University Irving Medical Center, New York

19104

Penn Presbyterian Medical Center, Philadelphia

22903

University of Virginia Medical Center, Charlottesville

27834

East Carolina University/Vidant Medical Center, Greenville

28025

Atrium Health, Concord

32207

Baptist Medical Center, Jacksonville

32209

University of Florida, Jacksonville

33744

Bay Pines VA, Bay Pines

40241

U of L Health/Jewish Hospital, Louisville

62769

Prairie Education & Research Cooperative / St. John's Hospital, Springfield

85224

Valley Heart Rhythm Specialists, Chandler

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elutia Inc.

INDUSTRY

NCT04645173 - Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation | Biotech Hunter | Biotech Hunter